A question came up about what "modality"means in the LAERTES evidence base.
First note that LAERTES consists of an evidence base (which contains data that can be used via some process to arrive at knowledge of a drug-HOI association) and an (as not yet created) knowledge base. Modality is currently only relevant to the evidence base
Each piece of evidence, identified by a drug-health outcomes of interest (HOI) pair and evidence type (e.g., case report, clinical study, product label mention, etc), has a modality indicates if this pair was a positive association (i.e. the drug and condition are considered an adverse reaction together) or negative association (i.e. it is known this drug does not cause this condition). SemMedDB is the only source with explicitly negative associations (e.g., see the “exact” column in the results of this query).
“The hyperventilatory response to hypoxia was not altered by propranolol.”
“Most of those with pre-treatment abnormalities of liver function developed abnormalities in their biopsies, not attributable to alcohol.”
etc…
The other datasources are assigned a positive modality because the presence of the evidence in the source means implicitly supports drug-HOI association (e.g., an HOI in a drug’s table of ADRs) or, the source does not provide a way to distinguish positive and negative evidence (e.g., MeSH tags indicate that a title and abstract is about a drug-HOI but there is no other information).
Clearly, this is up for discussion and hence this forum topic…